Does Ozempic Lower A1C? Semaglutide & Blood Sugar

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by mimicking a natural hormone that controls blood sugar and appetite, leading to measurable reductions in A1C levels within 8–12 weeks of treatment. Clinical trials show that people taking semaglutide achieve A1C drops of 1–2 percentage points on average, depending on baseline glucose levels and individual response. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, making this therapy accessible across all 50 states without insurance.

How Semaglutide Lowers Blood Sugar and A1C

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that activates specific pathways in your pancreas, brain, and gut. When you take semaglutide, it signals your pancreas to release insulin in response to meals, while simultaneously reducing the amount of glucose your liver produces between meals. This dual action creates a sustained lowering of blood sugar levels throughout the day, which translates into a lower A1C test result—your three-month average glucose reading.

The medication also slows the rate at which food moves through your stomach, keeping you fuller longer and reducing blood sugar spikes after eating. Research shows that semaglutide can lower A1C by 1.0–1.9 percentage points in people with type 2 diabetes, with the greatest reductions occurring in patients who started with higher baseline A1C levels. Unlike insulin injections, semaglutide does not typically cause dangerous low blood sugar episodes (hypoglycemia) when used as a standalone therapy.

Clinical Evidence: A1C Reduction Studies

Major randomized controlled trials, including SUSTAIN-6 and SUSTAIN-7, documented A1C reductions ranging from 1.0 to 1.9 percentage points when patients took semaglutide at doses of 0.5 mg to 1.0 mg weekly. In the SUSTAIN-6 trial, 82% of participants achieved an A1C below 7% (the standard diabetes control target), compared to 61% of those taking a comparison medication. These results held steady over two years, indicating sustained blood sugar control without requiring dose escalation for efficacy.

Studies also show that semaglutide works synergistically with other diabetes medications, including metformin, sulfonylureas, and SGLT-2 inhibitors. When combined with these drugs, A1C reductions can reach as high as 2.5 percentage points. Notably, the blood sugar benefits appear independent of weight loss, though many patients experience both—suggesting semaglutide's effect on A1C is driven by its metabolic action, not weight reduction alone.

Genetic Factors That Influence Your A1C Response

Not everyone responds to semaglutide in the same way, and part of that variation is rooted in your genetics. Specific genetic variants in the GLP1R and GIPR genes influence how effectively your cells recognize and respond to semaglutide signaling. PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) maps 14 metabolic pathways and analyzes key variants including GLP1R rs6923761 and GIPR rs1800437, revealing your individual predisposition to GLP-1 therapy response.

Your FTO rs9939609 variant and MC4R rs17782313 status also affect how your body regulates appetite and energy expenditure, which can influence both weight loss outcomes and blood sugar stability on semaglutide. Patients with higher-sensitivity genetic profiles may achieve A1C targets at lower doses, while others may require gradual dose escalation. Understanding your peptide genetics empowers PlexusDx to personalize your semaglutide protocol and set realistic A1C goals based on your unique biology.

PlexusDx Compounded Semaglutide vs. Brand Ozempic

PlexusDx semaglutide injections are compounded by licensed 503A pharmacies under strict quality and sterility standards, using the same active pharmaceutical ingredient as Ozempic. The key difference is accessibility: PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays. Your dose may need to go up as your body responds to treatment—your price won't, with flat-rate pricing starting at $149/mo across all dose levels.

Compounded semaglutide offers the same A1C-lowering efficacy as brand Ozempic while removing cost and insurance barriers. PlexusDx also provides optional genetic testing and dose adjustments based on your individual response, ensuring you reach your A1C target safely and affordably. HSA and FSA accounts are eligible for payment, adding another layer of financial flexibility for patients committed to long-term diabetes management.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will my A1C drop after starting semaglutide?

Most patients see measurable A1C reductions within 8–12 weeks of starting semaglutide, with the greatest improvements typically occurring by week 16. Your A1C test reflects your average blood sugar over three months, so the timing of your test relative to your start date matters. PlexusDx recommends repeating your A1C 12 weeks after starting or after any dose adjustment to track your progress.

Can semaglutide help with prediabetes and A1C prevention?

Yes. Clinical data shows semaglutide reduces A1C in people with prediabetes (A1C 5.7–6.4%), helping prevent progression to type 2 diabetes. The SUSTAIN-1 trial and real-world evidence support early intervention with semaglutide to halt glucose decline. PlexusDx can help prediabetic patients access compounded semaglutide without insurance or membership requirements.

What is the cost of semaglutide at PlexusDx?

PlexusDx compounded semaglutide injections start at $149/mo with flat-rate pricing across all dose levels—your dose may need to go up, your price won't. The medication is available nationwide without insurance, membership fees, or prior authorization. HSA and FSA funds are accepted for additional savings.

Are there side effects that could prevent me from reaching my A1C goal?

Common side effects include nausea, vomiting, and diarrhea, particularly during dose escalation—but these typically resolve within 1–2 weeks. Serious adverse events are rare with proper dosing and monitoring. PlexusDx provides personalized guidance to help you tolerate semaglutide and stay committed to reaching your A1C target without dangerous low blood sugar.

How does the PlexusDx Precision Peptide Genetic Test help with semaglutide therapy?

The Precision Peptide Genetic Test ($99 add-on after first month) analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways, revealing your individual predisposition to semaglutide response and A1C reduction potential. This test helps PlexusDx personalize your dose escalation schedule and set realistic A1C goals based on your unique peptide genetics.

Does Ozempic Help Lower A1C?